Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CORT | Common Stock | Award | $26.2K | +1.01K | +1.04% | $25.98 | 98.5K | Sep 1, 2022 | Direct | F1, F2 |
transaction | CORT | Common Stock | Award | $0 | +1.01K | +1.03% | $0.00 | 99.5K | Sep 1, 2022 | Direct | F3 |
holding | CORT | Common Stock | 5.81K | Sep 1, 2022 | Custodial Account for Child | F4 | |||||
holding | CORT | Common Stock | 5.81K | Sep 1, 2022 | Custodial Account for Child | F4 | |||||
holding | CORT | Common Stock | 5.81K | Sep 1, 2022 | Custodial Account for Child | F4 |
Id | Content |
---|---|
F1 | The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on September 1, 2022. |
F2 | In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. |
F3 | Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements under the Purchase Plan. |
F4 | These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. |
The power of attorney under which this form was signed is on file with the Commission.